Praxis Precision Medicines, Inc. (PRAX)
259.86
-3.69
(-1.40%)
USD |
NASDAQ |
Oct 09, 16:00
259.69
-0.17
(-0.07%)
After-Hours: 20:00
Praxis Precision Medicines Cash from Operations (Quarterly) : -77.19M for June 30, 2026
Cash from Operations (Quarterly) Chart
Historical Cash from Operations (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -77.19M |
| March 31, 2026 | -86.05M |
| December 31, 2025 | -77.26M |
| September 30, 2025 | -64.74M |
| June 30, 2025 | -54.36M |
| March 31, 2025 | -52.71M |
| December 31, 2024 | -56.96M |
| September 30, 2024 | -27.21M |
| June 30, 2024 | -27.00M |
| March 31, 2024 | -20.59M |
| December 31, 2023 | -23.60M |
| September 30, 2023 | -22.96M |
| June 30, 2023 | -30.96M |
| March 31, 2023 | -32.61M |
| Date | Value |
|---|---|
| December 31, 2022 | -28.57M |
| September 30, 2022 | -44.69M |
| June 30, 2022 | -56.88M |
| March 31, 2022 | -54.08M |
| December 31, 2021 | -44.66M |
| September 30, 2021 | -23.77M |
| June 30, 2021 | -29.82M |
| March 31, 2021 | -25.54M |
| December 31, 2020 | -20.05M |
| September 30, 2020 | -13.71M |
| June 30, 2020 | -9.773M |
| March 31, 2020 | -8.40M |
| December 31, 2019 | -9.789M |
Cash From Operations Definition
Represents the net cash flow from the company's business operations.
Cash from Operations (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (Quarterly) Benchmarks
| BioMarin Pharmaceutical, Inc. | 168.11M |
| Insmed, Inc. | -88.83M |
| Vertex Pharmaceuticals, Inc. | 1.125B |
| Ironwood Pharmaceuticals, Inc. | 58.28M |
| Xencor, Inc. | -55.66M |
Cash from Operations (Quarterly) Related Metrics
| Cash from Investing (Quarterly) | 10.98M |
| Cash from Financing (Quarterly) | 4.224M |
| Free Cash Flow | -306.32M |
| Free Cash Flow Per Share (Quarterly) | -2.685 |
| Free Cash Flow to Equity (Quarterly) | -77.86M |
| Free Cash Flow to Firm (Quarterly) | -78.21M |
| Free Cash Flow Yield | -4.47% |